Additionally, JTT increases the regulatory activities of T cells by decreasing the forkhead box p3 (Foxp3)+ regulatory T cell (Treg) population in patients with advanced pancreatic cancer [8]. This evidence concerns the gene FOXP3 and familial pancreatic carcinoma.